Life Edit News Today

Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease.

Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 expected product sales of approximately $4 billionInitiated three new clinical studies evaluating Moderna's investigational...

WALTHAM, Mass.--(BUSINESS WIRE)--Apr 22, 2024--

Explore Boston's vibrant biotech landscape with twelve innovative companies leading the charge in life sciences research.

Genome editing refers to a set of technologies enabling scientists to modify an organisms DNA by adding, removing, or altering genetic material at specific locations in the genome, as defined by MedlinePlus...

In this article, we discuss the top 11 CRISPR stocks to invest in. If you want to skip our discussion of the gene editing industry, head directly to Top 5 CRISPR Stocks To Invest In. Genome editing refers to a set of technologies enabling scientists to modify an organism’s DNA by adding, removing, or altering […]

WALTHAM, Mass.--(BUSINESS WIRE)--Jan 8, 2024--

The plan focuses on seven programmes for rare genetic disorders, cardiometabolic diseases

Gene editing from a Durham-based firm that will target possible new therapeutics has led to a deal with international drug firm Novo Nordisk worth a potential $2 billion if not more. Here are the details.

Novo Nordisk and Life Edit Therapeutics, Inc., an ElevateBio company focused on next-generation gene editing technologies and therapeutics, today announced a research and development collaboration to discover and develop gene editing therapies against a select set of therapeutic targets. With a focus on advancing ...